Last update 01 Apr 2025

AGN-193408

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AGN 193408, AGN193408
Target
PGF2α
Action
agonists
Mechanism
PGF2α agonists(Prostaglandin F2 alpha agonists)
Therapeutic Areas
Eye Diseases
Active Indication
Glaucoma, Open-Angle
Inactive Indication-
Originator Organization
AbbVie, Inc.AbbVie, Inc.
Active Organization
AbbVie, Inc.AbbVie, Inc.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with AGN-193408
NCT04499248
/ RecruitingPhase 1/2
A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
100 Clinical Results associated with AGN-193408
Login to view more data
100 Translational Medicine associated with AGN-193408
Login to view more data
100 Patents (Medical) associated with AGN-193408
Login to view more data
100 Deals associated with AGN-193408
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glaucoma, Open-AnglePhase 2
United States
AbbVie, Inc.AbbVie, Inc.
16 Nov 2020
Glaucoma, Open-AnglePhase 2
Japan
AbbVie, Inc.AbbVie, Inc.
16 Nov 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free